CTOS 2023 | Improving outcomes in patients with osteosarcoma

Odion Binitie, MD, Moffitt Cancer Center, Tampa, FL, provides an overview of strategies to enhance survival in patients with osteosarcoma who have early local progression. These group of patients tend to have worse outcomes, and Dr Binitie highlights the need to accurately define and characterize these patients in future clinical trials. This interview took place at the 2023 Connective Tissue Oncology Society (CTOS) Annual Meeting in Dublin, Ireland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.